上投摩根- 四張圖看懂醫藥行業巨大投資潛力 (in Chinese only)

2019-04-11 03:26
Share
  • Share

近期中國公司研發的抗腫瘤藥獲歐洲品管理局授予優先審批物認定,標志著原創創新藥首次真正走向了歐美市場, 並將投資者的目光重新聚焦到醫藥行業這條賽道上。





Related Articles

Manage your asset round-the-clock

Hotline

852
3896 3896

1501, 15/F, 101 King's Road,
North Point, Hong Kong

Mon - Fri (excluding public holidays)
09:00 - 18:00

Copyright © 2019 Noble Apex Advisors Limited. All Rights Reserved.